B-LCL-CDG4 Cells

B-LCL-CDG4 is an EBV-transformed B lymphocyte cell line derived from a young girl with CDAII. CDAII is a rare genetic anaemia, affiliated to the class of CDG glycosylation disorders. CDAII patients have a defect in the COPII component SEC23B gene which is involved in the intracellular protein transport system (in particular vesicular budding from ER). The respective patient is homozygous for the mutation in this gene. Band 3 glycoprotein of erythrocyte membranes is under glycosylated by aberrant glycosylation of polylactosamine motifs of glycoproteins but not of glycosphingolipids, thus band 3 of CDA II erythrocytes have truncated hybrid-type oligosaccharides. This points to an additional defect in the Golgi glycosylation enzymes mannosidase II or Nacetylglucosaminyltransferase II. Rare diseases - cell lines, Peripheral blood, Congenital Disorders of Glycosylation, Growth Conditions: Suspension, Cluster, Biosafety level: BSL 2